PB & T Project

PB & T Project Ltd

Staff down 20%ActiveLatest figures: 2021Filed as a small companyAbridged accountsCompany only14 years on the register

Private limited company registered in Rochester, classed under “Wholesale of pharmaceutical goods”.

Headline figures

FY to Dec 2021 · Company only

Turnover

For subscribers

Profit after tax

—

Not filed: small-company exemption

Net assets

For subscribers

Cash

For subscribers

Employees

For subscribers

Retained reserves

For subscribers

2 findings from the figures, in plain English

Written by rules from the figures on this page. Not a forecast or a credit opinion.

Pro

Every figure for all 2 years

“—” means we did not find the figure in a source; it is never filled with an estimate.

From the filed balance sheets · £

Balance sheet	2020	2021
Fixed assets
Current assets
of which debtors
of which cash
Creditors due within a year
Net current assets
Net assets
Ratios
Current ratioCurrent assets for every £1 owed within a year
Cash ratioCash for every £1 owed within a year
Creditors to assetsEverything owed to creditors as a share of fixed plus current assets

7 balance-sheet lines and 3 ratios, every year

A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.

›What does PB & T Project do?

Private limited company registered in Rochester, classed under “Wholesale of pharmaceutical goods”.

›How much turnover does PB & T Project make?

Answered in the full report

›Is PB & T Project profitable?

PB & T Project's profit isn't public: small companies may file without a profit and loss account.

›How many people work at PB & T Project?

Answered in the full report

›Where is PB & T Project based?

Its registered office is Cliffe House Anthonys Way, Medway City Estate, Rochester, ME2 4DY, in Rochester.

›When was PB & T Project founded?

PB & T Project Ltd was incorporated on 25 November 2011.

›Is PB & T Project still trading?

The register lists PB & T Project Ltd as active.